NasdaqGS - Nasdaq Real Time Price USD

Balchem Corporation (BCPC)

Compare
174.73 -3.55 (-1.99%)
At close: September 20 at 4:00 PM EDT
174.73 0.00 (0.00%)
After hours: September 20 at 4:16 PM EDT
Loading Chart for BCPC
DELL
  • Previous Close 178.28
  • Open 178.57
  • Bid 174.25 x 100
  • Ask 175.28 x 100
  • Day's Range 174.38 - 178.57
  • 52 Week Range 110.74 - 186.03
  • Volume 418,352
  • Avg. Volume 121,793
  • Market Cap (intraday) 5.669B
  • Beta (5Y Monthly) 0.65
  • PE Ratio (TTM) 48.81
  • EPS (TTM) 3.58
  • Earnings Date Oct 25, 2024 - Oct 29, 2024
  • Forward Dividend & Yield 0.79 (0.45%)
  • Ex-Dividend Date Dec 26, 2023
  • 1y Target Est 188.67

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

www.balchem.com

1,290

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BCPC

View More

Performance Overview: BCPC

Trailing total returns as of 9/20/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BCPC
17.47%
S&P 500
19.55%

1-Year Return

BCPC
34.52%
S&P 500
28.32%

3-Year Return

BCPC
26.69%
S&P 500
28.64%

5-Year Return

BCPC
78.99%
S&P 500
89.66%

Compare To: BCPC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BCPC

View More

Valuation Measures

Annual
As of 9/20/2024
  • Market Cap

    5.67B

  • Enterprise Value

    5.89B

  • Trailing P/E

    48.70

  • Forward P/E

    37.88

  • PEG Ratio (5yr expected)

    4.74

  • Price/Sales (ttm)

    6.10

  • Price/Book (mrq)

    5.10

  • Enterprise Value/Revenue

    6.32

  • Enterprise Value/EBITDA

    26.39

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    12.52%

  • Return on Assets (ttm)

    6.30%

  • Return on Equity (ttm)

    11.02%

  • Revenue (ttm)

    932.39M

  • Net Income Avi to Common (ttm)

    116.78M

  • Diluted EPS (ttm)

    3.58

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    63.74M

  • Total Debt/Equity (mrq)

    25.70%

  • Levered Free Cash Flow (ttm)

    135.3M

Research Analysis: BCPC

View More

Company Insights: BCPC

Research Reports: BCPC

View More

People Also Watch